Group B streptococci (GBS) is still the dominant cause of neonatal bacterial meningitis, whereas Escherichia coli (E. coli) is the most common cause among preterm infants, according to a study published in the March issue of The Pediatric Infectious Disease Journal.
MONDAY, March 21 (HealthDay News) -- Group B streptococci (GBS) is still the dominant cause of neonatal bacterial meningitis, whereas Escherichia coli (E. coli) is the most common cause among preterm infants, according to a study published in the March issue of The Pediatric Infectious Disease Journal.
Jean Gaschignard, M.D., of Hpital Antoine-Bclre in Clamart, France, and colleagues investigated the clinical and bacteriologic features of 439 cases of neonatal meningitis from 114 French pediatric wards between January 2001 and December 2007. Bacterial meningitis was classified as early-onset (day zero to day four) and late-onset (day five to day 28), and data were analyzed according to gestational age and birth weight.
The researchers found that 59 percent of cases were due to GBS, while E. coli accounted for 28 percent of the cases. The remaining cases were caused by Gram-negative bacilli other than E. coli (4 percent), other streptococci (4 percent), Neisseria meningitidis (3 percent), and Listeria monocytogenes (1.5 percent). GBS was the most common cause of early-onset (77 percent) and late-onset (50 percent) meningitis; whereas, E. coli was the most common bacteria isolated from preterm infants. In cases that involved seizures, GBS was present in 41 percent of cases and E. coli in 25 percent. The overall mortality rate was 13 percent, but it increased to 25 percent among preterm or small-for-gestational-age infants, regardless of the cause.
"At the dawn of the 21st century, GBS remains the dominant cause of neonatal bacterial meningitis in developed countries such as France," the authors write.
AbstractFull Text (subscription or payment may be required)
Related Content
Prevalence of the Bacterial Vaginosis and Group B Streptococcus in Term and Pre-term Pregnancies
Obstetrics, Pregnancy & Birth
Group B Strep: A Patient/Provider Approach for Optimizing Care
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More